Parvovirus B19 VP1 protein-VLP

N° du produit ABIN7489945

Cette protéine VLP Parvovirus B19 VP1 est produite dans Escherichia coli (E. coli).

Aperçu rapide pour Parvovirus B19 VP1 protein-VLP (ABIN7489945)

Antigène: Parvovirus B19 VP1

Type de proteíne: VLP

Origine: Human Parvovirus B19 (HPV B19)

Source: Escherichia coli (E. coli)

Application: Immunoassay (IA)

Détail du produit

Specificité: Parvovirus B19 PepA (VP1 unique) Antigen

Attributs du produit: E. coli derived recombinant protein

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

The VLPs are produced in SF9 insect cells (Baculovirus), purified by chromatography and suitable for the sensitive and specific detection of IgG and IgM antibodies against Parvovirus B19. The other seven recombinant Parvovirus B19 antigens (NS1, VP1, VP2, Pep A-D) are produced in E.coli and purified by chromatography in the presence of urea. Purity of ≥ 95% is confirmed via SDS-PAGE (Coomassie staining) for all recombinant antigens.,Parvovirus B19, recombinant protein A, VP1 unique region (VP1 aa 1-230). Molecular mass: 26 kDa.

Restrictions: For Research Use only

Stockage

Buffer: 50 mM Tris/HCl pH 8.0, 500 mM NaCl and 8 M urea

Stock: -80 °C

Détail du antigène

Antigène: Parvovirus B19 VP1

Autre désignation: Parvovirus B19 PepA (VP1)

Sujet: Parvovirus B19 was the first known human virus in the Parvoviridae family. During childhood it causes the ""childhood rash"" also called ""fifth disease"" or erythema infectiosum, but the virus can also affect adults.

Poids moléculaire: 26 kDa